Changeflow GovPing Healthcare & Life Sciences Process and Intermediates for the Preparation o...
Routine Notice Added Final

Process and Intermediates for the Preparation of Voxellotor

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The European Patent Office has published application EP3898618A1, filed by CURIA SPAIN, S.A.U., covering a process and intermediates for the preparation of Voxellotor, a compound used in the treatment of sickle cell disease. The application includes three named inventors and has been classified under multiple IPC subclasses covering heterocyclic and acyclic compounds. This publication makes the application publicly available for examination and potential opposition.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 31 changes logged to date.

What changed

EPO published application EP3898618A1 on April 15, 2026, covering a process and intermediates for preparing Voxellotor, a known pharmaceutical compound for sickle cell disease. The application designates all EU member states plus the UK, Switzerland, Norway, and other EPC contracting states.

Manufacturers and pharmaceutical companies involved in compound synthesis or generic drug development may wish to review this publication to assess freedom-to-operate implications. The application becomes part of the public record and may be cited in subsequent patent prosecution or litigation proceedings.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

PROCESS AND INTERMEDIATES FOR THE PREPARATION OF VOXELOTOR

Publication EP3898618A1 Kind: A1 Apr 15, 2026

Applicants

CURIA SPAIN, S.A.U.

Inventors

FERREIRO GIL, Juan José, IGLESIAS RETUERTO, Jesús Miguel, LORENTE BONDE-LARSEN, Antonio

IPC Classifications

C07D 405/14 20060101AFI20200701BHEP C07C 259/10 20060101ALI20200701BHEP C07D 319/08 20060101ALI20200701BHEP C07D 401/04 20060101ALI20200701BHEP C07D 405/12 20060101ALI20200701BHEP C07D 213/61 20060101ALI20200701BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3898618A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application Pharmaceutical compound preparation
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!